John W. Kozarich Sells Shares of Ligand Pharmaceuticals Inc.

On August 1, 2025, John W. Kozarich, a director of Ligand Pharmaceuticals Inc., sold 467 shares of the company's common stock at a price of $131.8755 per share. This transaction was executed under a pre-arranged trading plan adopted on March 7, 2025, in compliance with Rule 10b5-1. Following the sale, Kozarich owns 45,989 shares of Ligand Pharmaceuticals Inc. The transaction was reported in a Form 4 filing with the SEC.